Search results
Results from the WOW.Com Content Network
According to Harvard Health, hot flashes in men are most common in individuals who have undergone prostate cancer treatments that suppress testosterone to help prevent the continued growth of ...
The side effects of bicalutamide, a nonsteroidal antiandrogen (NSAA), including its frequent and rare side effects, have been well-studied and characterized. The most common side effects of bicalutamide monotherapy in men include breast tenderness, breast growth, feminization, demasculinization, and hot flashes.
Research on hot flashes is mostly focused on treatment options. The exact cause and pathogenesis, or causes, of vasomotor symptoms (VMS)—the clinical name for hot flashes—has not yet been fully studied. [11] [12] Hot flashes are associated with declining levels of estrogen (estrogen withdrawal) and other hormonal changes. [13]
Methyltestosterone, sold under the brand names Android, Metandren, and Testred among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women, and to treat ...
When triggered by such medical conditions or medications, hot flashes can happen to any women, and even men. In men, hot flashes can be triggered by erectile dy sfunction medication and treatments ...
For premium support please call: 800-290-4726 more ways to reach us
The rates of gynecomastia in men with selective AR antagonist monotherapy have been found to range from 30 to 85%. [102] In addition, antiandrogens can cause infertility, osteoporosis, hot flashes, sexual dysfunction (including loss of libido and erectile dysfunction), depression, fatigue, anemia, and decreased semen/ejaculate volume in males.
A Phase 3 trial showed that it improved hot flashes in slightly less than half of those who took it: 48% of women on a higher dose and 36% of those on a lower dose reported being much, or ...